• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖-三聚磷酸钠纳米颗粒的姜黄素药物递送系统的开发、表征及药代动力学研究

Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin.

作者信息

Arozal Wawaimuli, Louisa Melva, Rahmat Deni, Chendrana Priska, Sandhiutami Ni Made Dwi

机构信息

Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Faculty of Pharmacy, University of Pancasila, Jakarta, Indonesia.

出版信息

Adv Pharm Bull. 2021 Jan;11(1):77-85. doi: 10.34172/apb.2021.008. Epub 2020 Nov 7.

DOI:10.34172/apb.2021.008
PMID:33747854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961214/
Abstract

This study aimed to provide the method of preparation, characterization of curcumin-loaded chitosan-sodium tripolyphosphate (NaTPP) nanoparticle, and evaluate its pharmacokinetic profiles. Curcumin-loaded chitosan-NaTPP nanoparticles were synthesized using ionic gelation methods. Curcumin was dissolved using surfactants and cosurfactants. Chitosan polymer was then mixed in the curcumin solution and dripped with NaTPP solution until nanoparticle formation. The mucoadhesive study was evaluated by measuring the fluorescence of curcumin within the prepared nanoparticles. The pharmacokinetic profiles of curcumin particles and nanoparticles were then assessed in rats by administering a single oral dose of 100 mg/kg BW. Blood samples were taken from nine predetermined time points, and curcumin plasma concentrations were then analyzed using UPLC-MS/MS. The particle size of the curcumin nanoparticles obtained were 11.5 nm. Entrapment efficiency (EE) of curcumin nanoparticles were exceeding 99.97%, and drug loading capacity (DLC) was 11.34%. The mucoadhesive properties of the nanoparticles were superior to that of curcumin particles. Pharmacokinetic evaluation in rats revealed that curcumin nanoparticles resulted in an increase of area under the curve (AUC), maximum concentration (Cmax), earlier time to reach maximum concentration (Tmax), and lower clearance (CL). Curcumin-loaded chitosan-NaTPP nanoparticles is an effective formulation to improve curcumin plasma concentrations. Thus, enable its applications for the treatment of various diseases.

摘要

本研究旨在提供载姜黄素的壳聚糖-三聚磷酸钠(NaTPP)纳米颗粒的制备方法、表征,并评估其药代动力学特征。采用离子凝胶法合成了载姜黄素的壳聚糖-NaTPP纳米颗粒。姜黄素用表面活性剂和助表面活性剂溶解。然后将壳聚糖聚合物加入姜黄素溶液中,滴加NaTPP溶液直至形成纳米颗粒。通过测量制备的纳米颗粒中姜黄素的荧光来评估黏膜黏附性。通过单次口服给药100 mg/kg体重,在大鼠中评估姜黄素颗粒和纳米颗粒的药代动力学特征。在九个预定时间点采集血样,然后使用超高效液相色谱-串联质谱法(UPLC-MS/MS)分析姜黄素血浆浓度。所获得的姜黄素纳米颗粒的粒径为11.5 nm。姜黄素纳米颗粒的包封率(EE)超过99.97%,载药量(DLC)为11.34%。纳米颗粒的黏膜黏附性能优于姜黄素颗粒。大鼠药代动力学评估显示,姜黄素纳米颗粒导致曲线下面积(AUC)、最大浓度(Cmax)、达到最大浓度的时间(Tmax)增加,清除率(CL)降低。载姜黄素的壳聚糖-NaTPP纳米颗粒是提高姜黄素血浆浓度的有效制剂。因此,可使其应用于各种疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/88ef6b6e16fa/apb-11-77-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/8653b284874f/apb-11-77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/f5b4d70728a1/apb-11-77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/50e532645285/apb-11-77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/f99508666c91/apb-11-77-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/88ef6b6e16fa/apb-11-77-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/8653b284874f/apb-11-77-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/f5b4d70728a1/apb-11-77-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/50e532645285/apb-11-77-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/f99508666c91/apb-11-77-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/7961214/88ef6b6e16fa/apb-11-77-g005.jpg

相似文献

1
Development, Characterization and Pharmacokinetic Profile of Chitosan-Sodium Tripolyphosphate Nanoparticles Based Drug Delivery Systems for Curcumin.基于壳聚糖-三聚磷酸钠纳米颗粒的姜黄素药物递送系统的开发、表征及药代动力学研究
Adv Pharm Bull. 2021 Jan;11(1):77-85. doi: 10.34172/apb.2021.008. Epub 2020 Nov 7.
2
Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.用于改善眼部给药的马来酸噻吗洛尔壳聚糖纳米粒的研制
Pharm Nanotechnol. 2017;5(4):310-316. doi: 10.2174/2211738505666170828101559.
3
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
4
Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.壳聚糖载姜黄素纳米粒的制备及其黏附性能研究。
J Colloid Interface Sci. 2012 Mar 15;370(1):58-66. doi: 10.1016/j.jcis.2011.12.063. Epub 2012 Jan 8.
5
Synthesis, characterization and evaluation of anti-arthritic and anti-inflammatory potential of curcumin loaded chitosan nanoparticles.载姜黄素壳聚糖纳米粒的合成、表征及抗关节炎和抗炎活性评价。
Sci Rep. 2023 Jun 24;13(1):10274. doi: 10.1038/s41598-023-37152-7.
6
Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.含有壳聚糖包被纳米颗粒的粘膜粘附膜:一种用于口腔姜黄素释放的新策略。
J Pharm Sci. 2014 Nov;103(11):3764-3771. doi: 10.1002/jps.24142. Epub 2014 Sep 3.
7
Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.载有香草醛-壳聚糖修饰的四氧化三铁复合纳米粒的姜黄素药物递释系统。
Eur J Pharm Sci. 2018 Apr 30;116:48-60. doi: 10.1016/j.ejps.2018.01.023. Epub 2018 Feb 3.
8
Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.负载姜黄素的壳聚糖纳米颗粒的物理化学表征:对宫颈癌的影响
Anticancer Agents Med Chem. 2018;18(8):1131-1137. doi: 10.2174/1871520618666180412114352.
9
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.使用响应面法开发和优化负载姜黄素的甘露糖化壳聚糖纳米颗粒用于治疗内脏利什曼病
Expert Opin Drug Deliv. 2014 Aug;11(8):1163-81. doi: 10.1517/17425247.2014.917076. Epub 2014 May 29.
10
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.载利培酮壳聚糖纳米粒的鼻腔给药制剂及生物药剂学评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1342-1350. doi: 10.1080/03639045.2019.1619759. Epub 2019 Jun 3.

引用本文的文献

1
Formulation Development of Natural Polymeric Nanoparticles, In Vitro Antiaging Evaluation, and Metabolite Profiling of Leaf Extracts.天然聚合物纳米颗粒的制剂开发、体外抗老化评估及叶提取物的代谢物谱分析
Pharmaceuticals (Basel). 2025 Feb 20;18(3):288. doi: 10.3390/ph18030288.
2
Alginate and Chitosan-Based Delivery Systems for Improving the Bioavailability and Therapeutic Efficacy of Curcumin.基于海藻酸盐和壳聚糖的递送系统用于提高姜黄素的生物利用度和治疗效果。
Pharmaceutics. 2024 Mar 19;16(3):423. doi: 10.3390/pharmaceutics16030423.
3
Evaluation of curcumin-loaded chitosan nanoparticles for wound healing activity.

本文引用的文献

1
Pharmacokinetic Profile of Curcumin and Nanocurcumin in Plasma, Ovary, and Other Tissues.姜黄素和纳米姜黄素在血浆、卵巢及其他组织中的药代动力学特征。
Drug Res (Stuttg). 2019 Oct;69(10):559-564. doi: 10.1055/a-0863-4355. Epub 2019 Mar 18.
2
Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer.姜黄素和白藜芦醇:纳米医学方法助力有效治疗三阴性乳腺癌的天然良方
J Oncol. 2016;2016:9750785. doi: 10.1155/2016/9750785. Epub 2016 May 8.
3
Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).
负载姜黄素的壳聚糖纳米粒伤口愈合活性评估
ADMET DMPK. 2023 Aug 25;11(4):601-613. doi: 10.5599/admet.1897. eCollection 2023.
4
Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.抗生素眼部递送中纳米结构脂质载体的研究重点。
Pharm Nanotechnol. 2024;12(2):126-142. doi: 10.2174/2211738511666230727102213.
5
Chitosan-Based Particulate Carriers: Structure, Production and Corresponding Controlled Release.基于壳聚糖的微粒载体:结构、制备及相应的控释
Pharmaceutics. 2023 May 10;15(5):1455. doi: 10.3390/pharmaceutics15051455.
6
Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats.纳米姜黄素通过其抗氧化和抗炎作用,在顺铂治疗 DMBA 诱导的卵巢癌大鼠中,保存了肾脏功能和血液学参数。
Pharm Biol. 2023 Dec;61(1):298-305. doi: 10.1080/13880209.2023.2166965.
7
Enhancement of curcumin level and hepatoprotective effect in rats through antioxidant activity following modification into nanosized particles.通过纳米颗粒改性后的抗氧化活性提高大鼠体内姜黄素水平及肝保护作用。
Vet World. 2022 Sep;15(9):2323-2332. doi: 10.14202/vetworld.2022.2323-2332. Epub 2022 Sep 29.
8
Chitosan-Tripolyphosphate Nanoparticles Prepared by Ionic Gelation Improve the Antioxidant Activities of Astaxanthin in the In Vitro and In Vivo Model.通过离子凝胶法制备的壳聚糖-三聚磷酸钠纳米颗粒提高了虾青素在体外和体内模型中的抗氧化活性。
Antioxidants (Basel). 2022 Feb 28;11(3):479. doi: 10.3390/antiox11030479.
9
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA.姜黄素纳米颗粒通过抑制二甲基苯并蒽诱导的大鼠卵巢癌中的PI3K/AKT和JAK/STAT3信号通路增强顺铂的抗癌作用。
Front Pharmacol. 2021 Jan 18;11:603235. doi: 10.3389/fphar.2020.603235. eCollection 2020.
姜黄素在链脲佐菌素诱导的糖尿病大鼠中的药代动力学和药效学证据支持其抗糖尿病活性是通过代谢物实现的。
Evid Based Complement Alternat Med. 2015;2015:678218. doi: 10.1155/2015/678218. Epub 2015 May 3.
4
Cancer prevention and therapy through the modulation of the tumor microenvironment.通过调节肿瘤微环境进行癌症预防与治疗。
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10.
5
Nanotechnology-applied curcumin for different diseases therapy.应用纳米技术的姜黄素用于不同疾病的治疗。
Biomed Res Int. 2014;2014:394264. doi: 10.1155/2014/394264. Epub 2014 Jun 5.
6
Nanodrugs: pharmacokinetics and safety.纳米药物:药代动力学与安全性
Int J Nanomedicine. 2014 Feb 20;9:1025-37. doi: 10.2147/IJN.S38378. eCollection 2014.
7
The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.姜黄素及其代谢物在癌症方面的药代动力学和药效学的分子基础。
Pharmacol Rev. 2013 Dec 24;66(1):222-307. doi: 10.1124/pr.110.004044. Print 2014.
8
Novel curcumin oral delivery systems.新型姜黄素口服给药系统。
Anticancer Res. 2013 Jul;33(7):2807-21.
9
Nanocurcumin: a promising therapeutic advancement over native curcumin.纳米姜黄素:优于天然姜黄素的有前景的治疗方法。
Crit Rev Ther Drug Carrier Syst. 2013;30(4):331-68. doi: 10.1615/critrevtherdrugcarriersyst.2013007236.
10
New perspectives of curcumin in cancer prevention.姜黄素在癌症预防中的新视角。
Cancer Prev Res (Phila). 2013 May;6(5):387-400. doi: 10.1158/1940-6207.CAPR-12-0410. Epub 2013 Mar 6.